Merck & Company Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Accounts-Payable" stands at 4.15 Billion United States Dollars as of 09/30/2025, the highest value since 03/31/2023.
As of the end of Merck & Company Inc's third quarter, the item "Accounts Payable" stands at 4.15 Billion USD. This represents an increase of 6.55 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 15.64 percent compared to the value the year prior.
The 1 year change in percent is 15.64.
The 3 year change in percent is 23.02.
The 5 year change in percent is 10.76.
The 10 year change in percent is 104.99.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Accounts Payable | 905,699,262,464.00 |
![]() | Johnson & Johnson - Accounts Payable | 486,508,953,600.00 |
![]() | AbbVie Inc - Accounts Payable | 399,570,305,024.00 |
![]() | Roche Holding AG - Accounts Payable | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Accounts Payable | 280,205,508,085.11 |